Poster zum Thema "New Technology: MS-based Proteomics"

Zurück
  • P-I-0097
High throughput absolute quantitation of plasma proteins in young and old cohort
  • P-I-0098
Proximity labeling and SILAC based proteomic approach identifies proteins at the interface of homotypic and heterotypic cancer cell interactions
  • P-I-0099
Single-Cell proteomics using inCapS to dissect cellular states through protein correlation analysis
  • P-I-0100
High-throughput workflow for in-depth proteome coverage and quantitative analysis of low sample amounts and single-cells
  • P-I-0101
Unveiling proteomic insights: Orbitrap Astral's performance in multiplexed TMT analyses of brain Organoids in Alzheimer's disease research
  • P-I-0102
Novel data-independent acquisition (DIA) strategy for higher throughput quantitative proteomics
  • P-I-0103
Enabling scalable single-cell proteomics by utilizing the unique analytical properties of the Evotip Pure and Whisper Zoom methods
  • P-I-0104
A systematic optimization of diagonal-PASEF acquisition for low- to medium-input acquisitions on the timsTOF HT mass spectrometer
  • P-I-0105
Proteome-wide monitoring of drug action in living cells using a novel label-free solvent-based shift assay
  • P-I-0106
Single-cell proteomics and AP-MS to elucidate auditory mechanoelectrical transduction in mammalian cochlea
  • P-I-0107
SysQuan: a novel strategy for the absolute quantitation of human proteins
  • P-I-0108
Mass spectrometry-based single cell proteomic analysis of primary human neutrophils
  • P-I-0109
High-throughput high-resolution data-independent acquisition workflow on an Orbitrap exploris 480 hybrid mass spectrometer for accurate label-free quantitation
  • P-I-0110
Generation of ground-truth data for the systematic evaluation of data normalization strategies in single-cell proteomics data
  • P-I-0111
Regulation of Keratin 8 Phosphorylation during cancer cell division
  • P-I-0112
Single cell proteomics analysis: a way-to-do proposal
  • P-I-0113
Benchmarking TimsTOF HT and Orbitrap eclipse for deep proteome analysis using DDA and DIA workflows
  • P-I-0114
Ultra-high throughput workflow for robust and sensitive quantitative single cell analysis
  • P-I-0115
State-of-the-art glycopeptide identification using an Orbitral(TM)-Astral(TM) mass spectrometer
  • P-I-0116
Evaluation of midia-PASEF acquisition mode for the analysis of phosphoproteome samples
  • P-I-0117
Enhancing whole-proteome quantification in mass spectrometry-based proteomics with multi-point internal calibration curves
  • P-I-0118
Protein-Centric antibody repertoire profiling on a timsTOF: enhanced sensitivity using minimal sample volume
  • P-I-0119
Stability DIF-FRAC: a systematic characterization of protein complex stability
  • P-I-0120
Expanding TMTpro reagents to 32-plex for high-throughput quantitative proteomics on Orbitrap platforms
  • P-I-0121
Increasing throughput while maintaining coverage depths in single cell proteomics using the timsTOF Ultra
  • P-I-0122
Measuring proteome of 1,000 neutrophils directly isolated from inflammatory sites
  • P-I-0123
Ion mobility free high throughput peptide collisional cross-section measurements in fourier transform mass spectrometer on the proteome wide scale
  • P-I-0124
Unveiling hidden depths: A high-throughput plasma proteomics workflow on Orbitrap astral mass spectrometer for enhanced biomarker discovery
  • P-I-0125
Identifying drug targets with thermal proteome profiling using IBT-16plex
  • P-I-0126
Enhancing biomarker discovery: Automatable, enrichment-based plasma pipeline allows rapid and deep analysis of large sample cohorts
  • P-I-0127
Optimized DIA-MS workflow for Host Cell Proteins (HCP) characterization and quantification in bioreactors and top-down mass spectrometry analysis for monoclonal antibody production
  • P-I-0128
Intensity-based site localization of post-translational modifications utilizing predicted peptide fragmentation spectra
  • P-I-0129
Automated in-StageTip (iST)-based sample preparation for scaling up large cohort proteomics studies
  • P-I-0130
Enhancing protein quantification and sample throughput with the new TMTpro 32plex reagent and extended supporting features from thermo scientific Orbitrap ascend MultiOmics tribrid mass spectrometer
  • P-I-0131
Combining a new hybrid nominal mass platform and intelligent data acquisition to enable highly multiplexed targeted proteomics
  • P-I-0132
Wideband PRM with fully automated dual online reverse-phase liquid chromatography for High-throughput targeted proteomics
  • P-I-0133
Technical repeatability and efficiency in deep proteomics: a comparative study of various biological matrices
  • P-I-0135
Implementation of MS1 based real–time retention time adjustment on a hybrid Orbitrap mass spectrometer for directed and targeted proteomics
  • P-I-0136
Comparative glycosylation analysis of etanercept and its biosimilars using TMT labeling and ZIC-HILIC HPLC chromatography
  • P-I-0137
Human transcription factor interactions and environment
  • P-I-0138
Evaluation of high dynamic range MS1 acquisition methods on a hybrid Orbitrap mass spectrometer
  • P-I-0139
Assessment of high-resolution DIA methods and short gradients on high-throughput µPAC columns for maximum proteome coverage and quantitative performance
  • P-I-0140
Label-free DIA-based workflow for single-cell proteomic analysis on an Orbitrap Exploris 480 mass spectrometer
  • P-I-0141
Brucellin proteomic analysis for a standardized skin tests fostering Brucella infection diagnosis in animals
  • P-I-0142
Scalable single cell analysis towards 1000 samples per day using the Evosep whisper zoom methods on the timsTOF Ultra2
  • P-I-0143
Low-variation proteome profiling across 11 Labs, identifying 7200+ protein groups in 5 minutes with dia-PASEF
  • P-I-0144
Comparative evaluation of proteomics software suites for DDA and DIA acquisition strategies
  • P-I-0145
Development of a high-throughput kinase activity platform using nanoLC-MS/MS with DIA approach for studying the anti-cancer mechanism of Taxol in ovarian cancer
  • P-I-0146
High-throughput high-resolution data-independent acquisition workflow on an Orbitrap ascend MultiOmics tribrid mass spectrometer for accurate label-free quantitation
  • P-I-0147
Top-down and bottom-up analysis of proteins and PTMs using an Orbitrap-Omnitrap instrument equipped with ExD, UVPD and IRMPD
  • P-I-0148
Proteomic investigation of proteolytic processing dependent lysosomal hydrolase maturation
  • P-I-0149
Evaluation of plasma sample preparation methods for high-throughput mass spectrometry based proteomics and application to colorectal cancer
  • P-I-0150
Evaluation of diagonal-PASEF for data independent acquisition in proteomics
  • P-I-0151
Proteomic characterization of outbreak-associated Listeria monocytogenes strains in Italy: discovery of virulence markers
  • P-I-0152
Optimizing data-independent acquisition for the Orbitrap exploris 240: enhanced proteome coverage and quantitative accuracy and precision
  • P-I-0153
Application of targeted proteomics for quantification of protein targets to support PK/PD-modelling and TMDD de-risking of a bispecific agonistic antibody
  • P-I-0154
A multi-year longitudinal harmonization of quality controls in mass spectrometry proteomics core facilities
  • P-I-0155
Mass spectrometry acquisition methods for subcellular spatial proteomics: a direct comparison of resolution and reproducibility
  • P-I-0156
Quantifying 500 proteomics samples per day with ZT Scan DIA
  • P-I-0157
A mass-spectrometry-based approach for the detection of gene fusion products
  • P-I-0158
Elucidation of Caenorhabditis elegans germline protein-protein interaction networks by in vivo photo-crosslinking
  • P-I-0159
Broadening the horizon of MS optimization for enzymatic digestions in proteomics
  • P-I-0160
Automated high-throughput proteomic analysis of stored blood cells from a large cohort of non-domestic felids
  • P-I-0161
Label-Free quantitation with high accuracy and precision on a single cell scale and beyond with Orbitrap Astral mass spectrometer
  • P-I-0162
Refining advanced sample preparation and nanoLC-MS/MS analysis techniques for single-cell proteomics
  • P-I-0163
Multiple Accumulation Precursor Mass Spectrometry (MAP-MS) extends precursor dynamic range and improves peptide detection in data-independent analysis on an OrbitrapTM platform
  • P-I-0164
Exploring the influence of the number of Ions on the peptide fragmentation spectra
  • P-I-0165
Advancement in nanoparticle-based proteomic analysis of whole blood obtained from various dried blood spot collection devices
  • P-I-0166
hadexversum: tools for HDX-MS analysis
  • P-I-0167
Advanced proteomics for understanding cellular health and disease by unveiling lysosomal protein interactions
  • P-I-0168
Enabling ultra sensitive, superior-throughput proteomics from data acquisition to data analysis
  • P-I-0169
Mass spectrometry as a quantitative methodology to assess the biodistribution of monoclonal antibodies
  • P-I-0170
LC-MS/MS-based structural glycoproteomics
  • P-I-0172
Enrichment of transmembrane protein identification in mass spectrometry with the BeatBox® sample homogenizer
  • P-I-0173
Depletion-dependent activity-based protein profiling SWATH/DIA mass spectrometry discriminates aggressive lung adenocarcinomas through molecular abundances and catalytic action of serine hydrolases
  • P-I-0174
Revolutionizing translational research: large-scale targeted PRM proteomics assays enabled by a novel hybrid mass spectrometer
  • P-I-0175
Optimization of fractionation methods for cross-linking mass Spectrometry in studying protein-protein interactions and protein structures in complex mixtures
  • P-I-0176
Identification of biomarkers for diabetic kidney disease progression by utilizing a nanobinder-enabled deep plasma proteomics platform
  • P-I-0177
Absolute quantification of fluorescent proteins by mass spectrometry
  • P-I-0178
Probe the protein conformation using top-down hydrogen exchange mass spectrometry at higher resolution with electron transfer dissociation
  • P-I-0179
Profiling the proteome of tumor-derived exosomes in microliters of serum by liposome-mediated membrane fusion
  • P-I-0180
Chromatin-directed proteomics identifies cell vulnerabilities in DNA repair and elucidates the impact of signal transduction on the DNA-bound proteome
  • P-I-0181
Advancing single-cell proteomics for profiling tumour heterogeneity
  • P-I-0182
Addressing weather-driven ion mobility drifts in diaPASEF-based proteomics
  • P-I-0183
Rapid and in-depth proteomic analysis of CHO cell bioprocesses
  • P-I-0185
Getting faster, deeper biological insights using ZT Scan DIA
  • P-I-0186
Utilising data-independent acquisition mass spectrometry (DIA-MS) to enable rapid profiling of the human secretome
  • P-I-0187
Characterizing the performance of midia-PASEF – maximizing information content in data-independent acquistion
  • P-I-0188
Improving protein identification and quantitation using ZT Scan DIA
  • P-I-0189
Novel multi-reflecting TOF instruments: a compact multi-reflecting TOFMS (MRT) shines in both – top-down and DIA MSMS. Another MRT with 1 million resolution is for BUP quantitation at 20 ppb accuracy
  • P-I-0190
Improved proteome coverage combined with reproducible quantitation on the timsTOF platform
  • P-I-0191
Nanobinder based plasma protein capture enabled deep proteomic profiling identifies novel biomarkers for early cognitive decline in an aging population
  • P-I-0192
Proteonano™: a nanobinder-based proteomics platform for robust and standardized deep plasma proteomics study
  • P-I-0193
TSAP: a method for targeted signal amplification of peptides in phosphoproteome profiling
  • P-I-0194
Combining data independent acquisition with spike-in SILAC (DIA-SiS) improves proteome coverage and quantification
  • P-I-0195
ESPRESSO: a universal proteomic workflow based on a novel non-toxic dewaxing agent for FFPE samples
  • P-I-0196
Optimization of data-independent acquisition mass spectrometry coupled with FAIMS interface for highly quantitative proteomic analysis
  • P-I-0197
π-HelixNovoV2: Narrowing the gap between amino acid recall and peptide recall for de novo peptide sequencing
  • P-I-0198
High-throughput discovery of differential subcellular protein localization during chemotherapy resistance in triple-negative breast cancer
  • P-I-0199
Optimization of DIA for Accurate and Precise Label-Free Quantification in Proteomics
  • P-I-0200
Assessing protein and payload stability of antibody drug conjugate brentuximab vedotin in monkey plasma using agilent assayMAP bravo and agilent 6495 triple quadrupole LC/MS systems
  • P-I-0201
NovoCert: statistical validation of de novo peptide sequencing
  • P-I-0202
Trace sample proteome analysis by data-dependent acquisition without dynamic exclusion
  • P-I-0203
Degradation of different ubiquitinated proteoforms of tau proteins by the 20s proteasome
  • P-I-0204
Cell-based reactive cysteine profiling of an electrophile fragment library to explore novel target opportunities